Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
BioXcel Therapeutics
BTAI
$31.8M
| $1.24M | ﹤0.01% |
1,780
+1,742
| +4,584% | +$1.31M |
|
|
XEC
2477
PUT
DELISTED
CIMAREX ENERGY CO
XEC
| $1.23M | ﹤0.01% |
50,700
| – | – |
|
2478
PUT
Deckers Outdoor
DECK
$12.6B
| $1.23M | ﹤0.01% |
33,600
| – | – |
|
|
FLXN
2479
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.23M | ﹤0.01% |
118,310
+84,762
| +253% | +$1.04M |
|
2480
PUT
Range Resources
RRC
$9.34B
| $1.23M | ﹤0.01% |
185,800
| – | – |
|
2481
CALL
Adient
ADNT
$1.57B
| $1.23M | ﹤0.01% |
70,800
| – | – |
|
2482
Fulton Financial
FULT
$4.7B
| $1.23M | ﹤0.01% |
131,458
-4,523
| -3% | -$44.5K |
|
2483
Virtus Investment Partners
VRTS
$1.13B
| $1.22M | ﹤0.01% |
8,824
+957
| +12% | +$129K |
|
2484
Fortuna Silver Mines
FSM
$3.19B
| $1.22M | ﹤0.01% |
+192,300
| New | +$1.23M |
|
|
FOCS
2485
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $1.22M | ﹤0.01% |
37,208
-2,904
| -7% | -$103K |
|
2486
United Bankshares
UBSI
$6.68B
| $1.22M | ﹤0.01% |
56,693
-13,139
| -19% | -$342K |
|
|
STL
2487
DELISTED
Sterling Bancorp
STL
| $1.22M | ﹤0.01% |
115,740
-18,628
| -14% | -$211K |
|
2488
Carpenter Technology
CRS
$26.9B
| $1.22M | ﹤0.01% |
66,945
+30,139
| +82% | +$652K |
|
2489
Ares Management
ARES
$33.2B
| $1.22M | ﹤0.01% |
30,105
-14,038
| -32% | -$561K |
|
2490
Granite Construction
GVA
$5.41B
| $1.22M | ﹤0.01% |
68,958
+14,054
| +26% | +$257K |
|
|
INVX
2491
Innovex International
INVX
$2.18B
| $1.21M | ﹤0.01% |
49,007
+10,021
| +26% | +$319K |
|
2492
HealthStream
HSTM
$845M
| $1.21M | ﹤0.01% |
60,281
+15,856
| +36% | +$337K |
|
2493
PUT
Lennar Class A
LEN
$20.9B
| $1.21M | ﹤0.01% |
15,288
| – | – |
|
2494
ManpowerGroup
MAN
$2.73B
| $1.21M | ﹤0.01% |
16,483
+197
| +1% | +$14.2K |
|
2495
Safety Insurance
SAFT
$1.52B
| $1.21M | ﹤0.01% |
17,469
+4,081
| +30% | +$303K |
|
|
EGRX
2496
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.2M | ﹤0.01% |
28,360
+14,614
| +106% | +$639K |
|
2497
Enanta Pharmaceuticals
ENTA
$389M
| $1.2M | ﹤0.01% |
26,231
+8,255
| +46% | +$400K |
|
2498
Donaldson
DCI
$11.1B
| $1.2M | ﹤0.01% |
25,824
-43,720
| -63% | -$2.13M |
|
|
DBD
2499
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.2M | ﹤0.01% |
156,500
-11,100
| -7% | -$81.6K |
|
2500
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $1.19M | ﹤0.01% |
9,800
| – | – |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.